Utilizing the latest technology to transform diagnosis and treatment of patients
For women diagnosed with breast cancer, traditional radiation oncology treatments can cause radiation exposure to critical tissues and organs like the heart and lungs, which can lead to a low risk of long-term side effects.
This year, The Center for Cancer Care at St. Luke’s Hospital began utilizing the New Horizon™ Prone Breastboard. It allows for specialized positioning during radiation treatment, helping to better target a breast tumor or affected area of the breast while minimizing the radiation dose of critical organs like the heart and lungs. This new technology is especially helpful in treating early stage breast cancer.
Adopting technology innovations to improve breast cancer diagnosis and treatment
In the area of breast health, St. Luke’s also added two new technologies this year that help transform the breast screening experience for patients and improve breast cancer treatment.
St. Luke’s Women’s Center
PICTURED, SEATED, FROM LEFT: Paula George, MD; Abby Meier, BSN, RN, CN-BN; Angela Sqrow, WHNP-BC STANDING: Allison Roberts, MD; LaDawn Enke, BSN, RN, CN-BN; Patrice Seaman, RT(R)(M); Kristin Sauer, BSN, RN; Mari Fahrner, MD; Nanette Wendel, MD; Karen Hampel, BSN, RN; Sally Rappold, RN, CN-BN
Improving breast screening image capture and patient comfort
The SmartCurve breast stabilization system facilitates more uniform compression as compared with flat paddles while at the same time reducing the pressure needed to immobilize the breast. It also improves comfort in 93 percent of patients who report moderate to severe discomfort with standard compression methods, which can transform the patient experience, hopefully leading fewer women to delay or avoid getting regular breast health screenings due to fear of discomfort.
Improving surgical outcomes with advanced imaging technology
SPY Elite is the first and most advanced fluorescence imaging system that enables St. Luke’s surgeons performing breast reconstruction and plastic surgery to visualize microvascular blood flow and perfusion in tissue intraoperatively. This system assists surgeons in making critical decisions in the operating room, which has been shown to reduce rates of postoperative complications and decrease healthcare costs.
Implementing new technology to assist in the detection of Parkinson’s disease
This year, St. Luke’s became the first facility in the St. Louis region to adopt a new technology to assist in the detection of Parkinson’s disease. St. Luke’s and its nuclear medicine team comprise the only facility in the area utilizing DaTQUANT™ technology, an analytical tool that enhances the way a radiologist is able to view an imaging scan known as a DaTscan™ study. For individuals with neurodegenerative movement disorders, this can mean a more accurate diagnosis, which can lead to more appropriate and timely treatment.
New treatment provides relief and recovery to patients suffering from urinary tract symptoms
St. Luke’s urologists offer treatment with the UroLift® System, a one-time, outpatient surgery solution that provides rapid relief and recovery of benign prostatic hyperplasia (BPH) symptoms. This treatment is a proven, minimally invasive approach that can get men off BPH medications and avoid major surgery.
The UroLift System uses a revolutionary approach that lifts and holds the enlarged prostate tissue so it no longer blocks the urethra. It is the only BPH treatment performed by a urologist that does not require heating, cutting, or removal of the prostate tissue. Patients typically return home the same day without a catheter.